NON SMALL CELL LUNG CANCER NSCLC
Clinical trials for NON SMALL CELL LUNG CANCER NSCLC explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER NSCLC trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Lung cancer immunotherapy combo trial halted early
Disease control TerminatedThis study looked at whether giving two immunotherapy drugs (tiragolumab and atezolizumab) before and after surgery, with or without chemotherapy, is safe and effective for people with early-stage non-small cell lung cancer. The trial planned to enroll 50 participants but was ter…
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 26, 2026 03:14 UTC
-
New cancer drug trial halted early after testing in 95 patients
Disease control TerminatedThis study tested a new drug called TAK-186 in adults with advanced head and neck, lung, or colorectal cancer that could not be removed by surgery. The main goal was to check for side effects and find the best dose. The trial was stopped early, and 95 people took part.
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
Experimental KRAS drug trial halted early – what we know
Disease control TerminatedThis early-stage trial tested a new drug called AZD0022 in 17 people with advanced solid tumors (like lung, pancreatic, or colorectal cancer) that have a specific KRASG12D mutation. The study was stopped early, but researchers were checking if the drug is safe and shrinks tumors …
Matched conditions: NON SMALL CELL LUNG CANCER NSCLC
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 18, 2026 12:09 UTC